What Is TAVI

If you've been diagnosed with severe aortic stenosis and are experiencing symptoms, it's important to ask your doctor to explain the different treatment options to help you understand which treatment option could be best for you.

TAVI, which stands for transcatheter aortic valve implantation, is a less invasive1,2 way to replace your diseased aortic valve.

Is TAVI surgery?

Unlike surgery, TAVI does not involve opening the chest. Most patients return home the next day and have a shorter recovery time3-5, getting them back to their normal life. TAVI is reccommended for severe aortic stenosis patients who are experiencing symptoms and are over 75, and can be considered for all severe aortic stenosis patients who are experiencing symptoms.6

Learn more
Treatment can't wait. Ask your doctor if TAVI could be an option for you.

What happens during TAVI

TAVI is a less invasive1,2 procedure that replaces a diseased aortic valve. It is done through a small incision, typically in the groin. This is known as the transfemoral approach . A catheter is inserted into your artery through the incision while your heart is still beating. The catheter is then guided up to your heart, and the new valve is placed inside of your diseased aortic valve.

Other approaches for TAVI may be considered by your Heart Team depending on your individual anatomy. Learn more about what happens during TAVI, step by step.

How does TAVI compare to open heart surgery?

See how TAVI compares to open heart surgery:

What are the potential benefits of TAVI?7

Your life belongs to you, not severe aortic stenosis. Take it back with TAVI.

  • Relief of symptoms7
  • Improved quality of life following the procedure8,9
  • Most patients return home sooner and recover quicker4,5
  • Only requires a small incision which leaves a small wound which is easier to heal and less likely to become infected10

The most serious risks of TAVI include death, stroke, serious damage to the arteries, or serious bleeding.

Wondering if you qualify?
Learn more
Map location

Let your doctor know that you want to be involved in the treatment decision so that you can chose the treatment that supports your life goals

Make sure you speak to your cardiologist and/or Heart Tean about your teatment options and life goals, as your preferences and wishes will help decide your treatment.

Free TAVR info kit

Want more information delivered directly to you?

Get a free information kit by email or mail to learn more about severe aortic stenosis and TAVI as a treatment option.

What you’ll receive in your kit:

  • Education on severe aortic stenosis and symptoms checklist once it becomes severe
  • Information on TAVI as a treatment option
  • Discussion guide for talking with your doctor
Order your free info kit

References
1. Kleczynski P, Bagieński M, Sorysz D et al. Short- and intermediate-term improvement of patient quality of life after transcatheter aortic valve implantation: A single-centre study. Kardiol Pol. 2014;72(7):612–616. doi: 10.5603/KP.a2014.0065.
2. Reynolds MR, Magnuson EA, Wang K et al. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiel. 2012;60(6):548–558. doi: 10.1016/j.jacc.2012.03.075.
3. Mack MJ, Leon M, thourani VH et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 20l9;380(18):1695–1705 and supplementary material. doi: 10.1056/NEJMoa1814052.
4. Thourani VH, Kodali S, Makkar RR et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387(10034):2218–2225. doi: 10.1016/S0140-6736(16)30073–3.
5. Leon MB, Smith CR, Mack MJ et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 20l6;374(17):1609–1620. doi: 10.1056/NEJMoa1514616.
6. 21 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2022;43(7):561–632. doi:10.1093/eurheartj/ehab395.
7. Otto CM. Timing of aortic valve surgery. Heart. 2000;84(2):211–218. doi: 10.1136/heart.84.2.211.
8. Baron SJ, Magnuson EA, Lu M et al. Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis. J Am Coll Cardiol. 20l9;74(23):2833–2842. doi: 10.1016/j.jacc.2019.09.007.
9. Barbanti M, Van Mourik MS, Spense MS et al. Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial. Eurolntervention. 20l9;15:147–154. doi: 10.4244/EIJ-D-18-01197.
10. Shehada SE, Wendt D, Peters D et al. Infections after transcatheter versus surgical aortic valve replacement: mid-term results of 200 consecutive patients. J Thorac Dis. 2018;10(7):4342–4352.

PP--EU-7600 v1.0